Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics

por Tempark, Therdpong, John, Shobana, Rerknimitr, Pawinee, Satapornpong, Patompong, Sukasem, Chonlaphat
Publicado 2022

Association of HLA-B*51:01, HLA-B*55:01, CYP2C9*3, and Phenytoin-Induced Cutaneous Adverse Drug Reactions in the South Indian Tamil Population

por John, Shobana, Balakrishnan, Karuppiah, Sukasem, Chonlaphat, Anand, Tharmarajan Chinnathambi Vijay, Canyuk, Bhutorn, Pattharachayakul, Sutthiporn
Publicado 2021

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand

por Tiwattanon, Kanyawan, John, Shobana, Koomdee, Napatrupron, Jinda, Pimonpan, Rachanakul, Jiratha, Jantararoungtong, Thawinee, Nuntharadthanaphong, Nutthan, Kloypan, Chiraphat, Biswas, Mohitosh, Boongird, Apisit, Sukasem, Chonlaphat
Publicado 2022

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand

por Koomdee, Napatrupron, Kloypan, Chiraphat, Jinda, Pimonpan, Rachanakul, Jiratha, Jantararoungtong, Thawinee, Sukprasong, Rattanaporn, Prommas, Santirhat, Nuntharadthanaphong, Nutthan, Puangpetch, Apichaya, Ershadian, Maliheh, John, Shobana, Biswas, Mohitosh, Sukasem, Chonlaphat
Publicado 2022